Dentsply Sirona and Siemens Healthineers' ddMRI system receives FDA clearance, enhancing dental imaging without ionizing radiation.
Quiver AI Summary
Dentsply Sirona and Siemens Healthineers have announced that their MAGNETOM Free.Max Dental Edition, the first dental-dedicated MRI system, has received FDA clearance in the U.S. This follows a successful clinical trial demonstrating its potential in various dental specialties, including endodontics and orthodontics, by providing non-ionizing imaging that enhances diagnosis and treatment planning. The system features a specialized dental coil and software tailored for dental structures, allowing for efficient imaging with an average workflow time under 20 minutes. Its advanced capabilities include differentiating inflammation and assessing tooth pulp vitality, which can improve diagnostic confidence compared to current imaging methods. Clinicians interested in adopting this technology can participate in a training program in April 2026 at the University of Minnesota.
Potential Positives
- The MAGNETOM Free.Max Dental Edition has received FDA clearance, marking a significant regulatory achievement and milestone for Dentsply Sirona.
- The clinical trial validated the system’s potential across multiple dental specialties, indicating its wide applicability and improving diagnostic capabilities.
- The system offers non-ionizing imaging capabilities, enhancing safety for patients compared to traditional imaging methods.
- Advanced clinical training opportunities for clinicians indicate Dentsply Sirona's commitment to educating professionals about this innovative technology, which could lead to broader adoption and increased market presence.
Potential Negatives
- System's unavailability in all countries and potential regulatory issues may limit its market reach and growth opportunities.
- The press release does not mention any specific partnerships or plans for commercialization, which may indicate uncertainty in market adoption.
- Potential high cost and resource implications for clinics adopting the new technology could limit accessibility for some dental practices.
FAQ
What is the MAGNETOM Free.Max Dental Edition?
The MAGNETOM Free.Max Dental Edition is the first dental-dedicated MRI system that has received FDA clearance in the U.S.
How can ddMRI improve dental imaging?
ddMRI offers advanced soft tissue contrast and non-ionizing imaging, enhancing diagnosis and treatment planning in various dental specialties.
What specialties can benefit from the MAGNETOM Free.Max?
This system benefits endodontics, periodontics, TMJ, tooth extraction, and orthodontics by providing accurate imaging of dental structures.
Where can clinicians learn about advanced ddMRI training?
Clinicians can attend a hands-on training program at the University of Minnesota in April 2026 focusing on ddMRI imaging protocols.
When and where will the ADEA Annual Session take place?
The ADEA Annual Session is scheduled for March 21–24, 2026, in Montréal, Canada, featuring the ddMRI system.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$XRAY Insider Trading Activity
$XRAY insiders have traded $XRAY stock on the open market 4 times in the past 6 months. Of those trades, 3 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $XRAY stock by insiders over the last 6 months:
- GREGORY T LUCIER has made 2 purchases buying 50,000 shares for an estimated $707,379 and 1 sale selling 82,200 shares for an estimated $915,708.
- LESLIE F VARON purchased 9,337 shares for an estimated $99,999
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$XRAY Revenue
$XRAY had revenues of $961M in Q4 2025. This is an increase of 6.19% from the same period in the prior year.
You can track XRAY financials on Quiver Quantitative's XRAY stock page.
$XRAY Hedge Fund Activity
We have seen 152 institutional investors add shares of $XRAY stock to their portfolio, and 298 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AQR CAPITAL MANAGEMENT LLC removed 7,602,230 shares (-60.8%) from their portfolio in Q4 2025, for an estimated $86,893,488
- ARIEL INVESTMENTS, LLC added 5,274,740 shares (+inf%) to their portfolio in Q4 2025, for an estimated $60,290,278
- DIMENSIONAL FUND ADVISORS LP removed 2,515,798 shares (-48.1%) from their portfolio in Q4 2025, for an estimated $28,755,571
- NORGES BANK removed 2,203,362 shares (-88.1%) from their portfolio in Q4 2025, for an estimated $25,184,427
- MARSHALL WACE, LLP added 2,039,280 shares (+1032.5%) to their portfolio in Q4 2025, for an estimated $23,308,970
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,790,971 shares (-73.9%) from their portfolio in Q4 2025, for an estimated $20,470,798
- ARMISTICE CAPITAL, LLC added 1,562,000 shares (+27.2%) to their portfolio in Q4 2025, for an estimated $17,853,660
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$XRAY Analyst Ratings
Wall Street analysts have issued reports on $XRAY in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barrington Research issued a "Outperform" rating on 01/05/2026
To track analyst ratings and price targets for $XRAY, check out Quiver Quantitative's $XRAY forecast page.
$XRAY Price Targets
Multiple analysts have issued price targets for $XRAY recently. We have seen 9 analysts offer price targets for $XRAY in the last 6 months, with a median target of $15.0.
Here are some recent targets:
- Steven Valiquette from Mizuho set a target price of $16.0 on 03/02/2026
- Michael Petusky from Barrington Research set a target price of $17.0 on 03/02/2026
- Vik Chopra from Wells Fargo set a target price of $13.0 on 02/27/2026
- Elizabeth Anderson from Evercore ISI Group set a target price of $15.0 on 02/27/2026
- Jeffrey Johnson from Baird set a target price of $14.0 on 02/27/2026
- Michael Cherny from B of A Securities set a target price of $17.0 on 02/19/2026
- Kevin Caliendo from UBS set a target price of $16.0 on 02/03/2026
Full Release
Dentsply Sirona and Siemens Healthineers are pleased to announce that the first-ever dental-dedicated MRI 1 (ddMRI) system – MAGNETOM Free.Max Dental Edition – has received FDA clearance in the United States. This milestone follows the completion of a clinical trial 2 validating the system’s significant potential across multiple dental specialties. The trial highlighted this first-of-its-kind technology’s applicability in endodontics, periodontics, TMJ, tooth extraction, and orthodontics, offering non-ionizing imaging capabilities that can enhance diagnosis and treatment planning.
CHARLOTTE, N.C., March 09, 2026 (GLOBE NEWSWIRE) -- Dentsply Sirona and Siemens Healthineers are pleased to share key findings from the clinical trial for validation of their dental-dedicated MRI system . In addition to confirming its significant potential across multiple dental specialties, the trial also underscored the ddMRI system’s specialized features designed to meet the unique needs of dental professionals. Among these features is a dental-specific field of view, enabled by a dedicated dental coil and specialized software that focuses exclusively on dental structures, ensuring no brain tissue is visible and allowing for accurate imaging of dental structures. Additionally, the system’s ability to streamline patient preparation and maintain an average workflow time of under 20 minutes 3 makes it a highly efficient tool for clinical use.
Clinical highlights from the trial demonstrated MAGNETOM Free.Max Dental Edition’s ability to differentiate active inflammation from healthy and scar tissue, enable non-invasive assessment of tooth pulp vitality to support chairside testing and observations and enables the visualization of teeth and their position in relation to neighboring teeth as well as the nerves.
“MAGNETOM Free.Max Dental Edition represents a significant advancement in dental imaging, providing excellent insights into dental structures that were not readily visible in other imaging modalities, without the risks associated with ionizing radiation. The ability to observe the same region of interest employing different ddMRI imaging sequences provides significantly more information regarding the pathological processes in hard and soft tissues which results in a more accurate understanding of the lesion. This capacity to see the clarity of the soft tissue detail produced by ddMRI has clear potential to enhance diagnostic confidence in areas where current modalities have limitations,” said Prof. Don Tyndall, DDS, MSPH, PhD, FICD, FACD; Diplomate ABOMR, Professor of Diagnostic Sciences at University of North Carolina, who reviewed the clinical trial findings and collaborated in the FDA clearance process.
Dental-dedicated MRI: excellent complement to existing imaging solutions
As an ionizing radiation-free modality with advanced soft tissue contrast, ddMRI complements intraoral, panoramic, and CBCT imaging by addressing diagnostic questions where soft tissue characterization is critical.
MAGNETOM Free.Max Dental Edition, the first-of-its-kind dental-dedicated MRI, was developed jointly by Dentsply Sirona, Siemens Healthineers, and leading scientists in Europe and the United States. Specifically designed to enhance dentomaxillofacial diagnostics, ddMRI is primarily intended for hospitals, large clinics, and universities, and offers advanced soft tissue contrast through ionizing radiation-free imaging.
“This innovation is a powerful addition to our imaging portfolio , which includes Axeos, Orthophos SL, and Heliodent Plus, among others. We’re proud to have contributed to developing the industry’s first dental dedicated MRI and the advancement of diagnostic capabilities in the field,” observed Dan Scavilla, President & CEO of Dentsply Sirona.
“We are dedicated to expanding the clinical impact and reach of MRI. We are excited to see the potential of ddMRI being validated through clinical trials, which will pave the way for a new clinical field that will benefit dental practitioners and patients alike,” said Andreas Schneck, head of Magnetic Resonance at Siemens Healthineers.
Advanced Clinical Training Opportunity
Clinicians interested in incorporating ddMRI into their practice can participate in an advanced, hands‑on training program taking place in April 2026 at the University of Minnesota. This two‑day course covers ddMRI imaging protocols, recommended clinical procedures, essential MR facility and patient safety guidelines, hands‑on image acquisition, and practical interpretation sessions featuring TMJ and dental cases.
For more details, please visit Introduction to Dental MRI: A Hands‑on Program | School of Dentistry .
Learn more at the upcoming American Dental Education Association (ADEA) Annual Session
Visit the Dentsply Sirona booth at the American Dental Education Association (ADEA 2026) Annual Session, taking place March 21–24 in Montréal, Canada, and learn more about the first dental-dedicated magnetic resonance imaging (ddMRI) system.
Learn more at www.dentsplysirona.com/ddmri
Registered brands, trade names and logos are used. Even in particular cases, when they appear without a TM or ®, all corresponding legal rules and provisions apply. All rights are retained by Dentsply Sirona. Clinicians may have been compensated for use of their experiences and testimonials.
About Dentsply Sirona
Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands. Dentsply Sirona’s innovative products provide high-quality, effective and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona is headquartered in Charlotte, North Carolina. The Company’s shares are listed in the United States on Nasdaq under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.
Contact Information:
Dentsply Sirona Press Contact:
Marion Par-Weixlberger
Vice President, Public Relations, Corporate Communications & Brand
[email protected] | www.dentsplysirona.com
Siemens Healthineers Press Contact:
Stefanie Haug | Magnetic Resonance Imaging, Computed Tomography and X-ray
+49 173 6358240 | [email protected]
1 The product mentioned here is not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed.
2
Clinical Evaluation Report, MAGNETOM Free.Max Dental Edition, 2025. Copyright@Siemens Healthineers. Data on file.
3
Greiser et al. (2023): Dental-dedicated MRI, a novel approach for dentomaxillofacial diagnostic imaging: technical specifications and feasibility, in: Dentomaxillofacial Radiology, 2023, 00, 1-12